Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Registration
Attend
Access TLMdX
Claim CE Credits
Program
Call for Abstracts
On-Site Guides
Experience
The Park @ TLM
Register for TLMdX
MTE #30: Drug-Induced Autoimmune-Like Hepatitis: Diagnostic and Therapeutic Challenges (Ticketed)
Nov
18
2024
Convention Center: Room 33 B
7:00 AM - 7:45 AM
Ticketed Event
World Class Speakers
Discussion Leader
Raul Andrade, MD, PhD, FAASLD
IBIMA-Plataforma BIONAND, UMA, CIBERehd
Discussion Leader
Nelia Hernandez, MD
Clinicas Hospital, Faculty of Medicine
Description
Experts discuss the drugs that commonly mimic autoimmune hepatitis and the challenges associated with diagnosis and management of this disorder.
Journey Maps
Acute Liver Failure
Drug-Induced Liver Injury
Objectives
Identify which drugs commonly cause drug-induced autoimmune-like hepatitis.
Describe how the management of drug-induced autoimmune-like hepatitis differs from that of autoimmune hepatitis.